Latest (Dec 2023) Quarterly:
"Regulatory activities continue to progress
EBR made significant progress regarding key regulatory activities during the quarter. Following the Company’s update in November 2023, EBR is scheduled to submit the final module of its PMA submission in Q3 2024 and is targeting FDA approval in Q1 2025."
Video: EBR Systems’ (ASX:EBR) pacemaker the size of a grain of rice, page-3
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.030(2.88%) |
Mkt cap ! $328.1M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.08 | $1.02 | $106.2K | 101.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 17975 | 1 |
View Market Depth
| Last trade - 15.32pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.030 ( 6.15 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.08 | $1.02 | 46378 | ||
| Last updated 14.58pm 17/06/2024 ? | |||||
| EBR (ASX) Chart |
